company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:06:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1092665.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:06:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1099644.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:06:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2192309.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:06:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2192309.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:06:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2192309.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:06:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2192309.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:06:29+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,2658.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:06:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2189651.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:06:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2189651.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:06:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1500000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:06:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.42
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:06:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1500000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:06:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.42
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:06:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1539463.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 17:06:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.42
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3216212.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2804946.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6021158.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6021158.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6021158.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6021158.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,3577.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6017581.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6017581.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10200000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.59
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10200000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.59
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,10179955.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 17:18:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.59
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:54:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:54:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:54:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3904403.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:54:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3190178.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:54:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7094581.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:54:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7094581.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:54:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7094581.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:54:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7094581.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:54:07+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,16183.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:54:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7078398.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:54:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7078398.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:54:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15100000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:54:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.47
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:54:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15100000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:54:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.47
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:54:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15034764.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q2,2015-04-01,2015-06-30,2016-08-03 16:54:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.47
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:43:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:43:12+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:43:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:43:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4722281.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:43:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3445200.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:43:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8167481.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:43:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8167481.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:43:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8167481.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:43:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8167481.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:43:12+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,14637.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:43:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8152844.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:43:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8152844.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:43:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15400000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:43:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.53
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:43:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15400000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:43:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.53
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:43:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15290435.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 16:43:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.53
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4621383.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3309055.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7930438.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7930438.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7930438.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7930438.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,37631.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7892807.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7892807.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,14000000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,14000000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,14032916.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,197020.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,197020.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-197020.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5111695.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4387079.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9498774.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9695794.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9695794.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9695794.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,103333.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9592461.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9592461.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,15700000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.61
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,15700000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.61
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,15843532.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 16:48:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.61
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,112685.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,112685.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,110931.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,110931.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1754.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5377784.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6094921.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11472705.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11470951.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11470951.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11470951.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,107818.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11363133.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11363133.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16000000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.71
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16000000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.71
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16105555.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:11:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.71
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,586134.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,12940.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,599074.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,221090.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,221090.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,377984.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5447847.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5665357.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11113204.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10735220.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10735220.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10735220.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,97726.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10637494.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10637494.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16400000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.65
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16400000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.65
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16361617.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 08:43:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.65
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,311844.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-12940.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,298904.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,303706.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,303706.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-4802.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3918661.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4230804.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-170000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8149465.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7984267.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7984267.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7984267.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,84232.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7900035.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7900035.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16300000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.46
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16300000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.46
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16233985.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.46
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,240292.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,2255.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,242547.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,79106.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,79106.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,163441.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4594716.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3914974.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8509690.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8346249.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8346249.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8346249.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,77854.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8268395.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8268395.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,16900000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,16900000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,16873512.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q1,2017-01-01,2017-03-31,2017-05-03 16:48:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:31:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,335523.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:31:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,335523.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:31:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,145325.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:31:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,145325.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:31:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,190198.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:31:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4990943.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:31:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4076220.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:31:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9067163.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:31:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8876965.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:31:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8876965.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:31:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8876965.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:31:25+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,72342.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:31:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8804623.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:31:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8804623.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:31:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17300000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:31:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:31:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17300000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:31:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:31:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17130264.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q2,2017-04-01,2017-06-30,2018-08-01 16:31:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:11:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,413601.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:11:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,413601.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:11:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,148756.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:11:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,148756.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:11:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,264845.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:11:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4934937.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:11:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4739360.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:11:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9674297.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:11:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9409452.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:11:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9409452.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:11:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9409452.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:11:36+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,77339.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:11:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9332113.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:11:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9332113.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:11:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17300000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:11:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.54
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:11:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17300000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:11:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.54
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:11:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17386249.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 16:11:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.54
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,285083.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-2255.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,282828.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,133343.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,133343.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,149485.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3983088.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4259357.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8242445.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8092960.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8092960.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8092960.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,64429.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8028531.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8028531.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17300000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.45
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17300000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17260626.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.45
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,178582.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,178582.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,108934.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,108934.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,69648.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3697287.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4680181.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8377468.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8282820.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8282820.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8282820.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,59593.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8223227.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8223227.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17900000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.46
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17900000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.46
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,17893912.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:11:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.46
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 17:02:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,245502.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 17:02:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,245502.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 17:02:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,208945.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 17:02:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,208945.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 17:02:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36557.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 17:02:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2994649.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 17:02:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6174589.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 17:02:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9169238.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 17:02:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9103681.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 17:02:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9103681.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 17:02:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9103681.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 17:02:47+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,51809.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 17:02:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9051872.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 17:02:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9051872.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 17:02:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18100000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 17:02:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.5
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 17:02:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18100000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 17:02:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.5
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 17:02:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18037274.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 17:02:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.5
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,469051.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,469051.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,469051.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,428958.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,353607.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,782565.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-313514.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6064.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6064.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-307450.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-307450.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-307450.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,24580.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-332030.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1700000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1700000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1653340.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:31:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1058216.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1058216.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-317879.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-317879.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1376095.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-4772533.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-9920756.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-14693289.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,16015384.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8930.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8930.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,16024314.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16024314.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-111402.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15912912.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,99147.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15813765.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1500000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1500000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1539388.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,104977.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,104977.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,47329.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,47329.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,57648.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2299585.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1706.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2301291.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2243643.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2243643.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2243643.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,13213.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2230430.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2230430.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,18600000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,18600000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18067807.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q1,2019-01-01,2019-03-31,2019-05-01 16:11:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 17:02:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,164705.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 17:02:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,164705.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 17:02:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,36148.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 17:02:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,36148.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 17:02:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,128557.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 17:02:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1497401.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 17:02:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29294.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 17:02:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1526695.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 17:02:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1398138.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 17:02:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1398138.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 17:02:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1398138.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 17:02:47+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,13361.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 17:02:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1384777.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 17:02:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1384777.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 17:02:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,17300000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 17:02:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 17:02:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,17300000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 17:02:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 17:02:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,18068429.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 17:02:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,874949.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,874949.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,874949.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3494205.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1140909.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4635114.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3760165.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-752.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1130848.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1130096.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2630069.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2630069.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,2348.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2627721.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2627721.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3600000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.73
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3600000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.73
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3605913.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:31:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.73
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2320424.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2320424.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-83477.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-83477.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2403901.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,419990.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2847042.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3267032.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-863131.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16400.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,180485.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,196885.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-666246.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-666246.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-515.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-26574.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-693335.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-693335.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3300000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.19
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3300000.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.19
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,3268637.0
Flex Pharma Inc,FLKS,549300CLUMLZXIHU7X22,0001615219,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.19
